These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 826978)

  • 1. High-dose treatment of rats with perphenazine enanthate.
    Fog R; Pakkenberg H; Juul P; Bock E; Jorgensen OS; Andersen J
    Psychopharmacology (Berl); 1976 Nov; 50(3):305-7. PubMed ID: 826978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations.
    Pakkenberg H; Fog R; Nilakantan B
    Psychopharmacologia; 1973; 29(4):329-36. PubMed ID: 4707024
    [No Abstract]   [Full Text] [Related]  

  • 3. Corpus striatum in paralysis agitans and in perphenazine-injected rats.
    Pakkenberg H; Bottcher J
    Adv Neurol; 1974; 5():203-9. PubMed ID: 4440571
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.
    Nudelman A; Gil-Ad I; Shpaisman N; Terasenko I; Ron H; Savitsky K; Geffen Y; Weizman A; Rephaeli A
    J Med Chem; 2008 May; 51(9):2858-62. PubMed ID: 18363346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in contacts between glial cells and neurons following motor excitation evoked by phenamine].
    Matveeva TG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(1):55-60. PubMed ID: 5020154
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of perphenazine enanthate in Pyrenean chamois (Rupicapra pyrenaica).
    Marco I; Cabezón O; Mentaberre G; Fernández-Sirera L; Casas-Díaz E; Fernandez-Aguilar X; López-Olvera JR; Serrano E; Navarro-Gonzalez N; Lavín S; Manteca X
    J Zoo Wildl Med; 2013 Dec; 44(4):1083-5. PubMed ID: 24450074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour.
    Fog R; Randrup A; Pakkenberg H
    Psychopharmacologia; 1970; 18(4):346-56. PubMed ID: 5531020
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot perphenazine decanoate and enanthate for schizophrenia.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of long-term sedation in cheetah (Acinonyx jubatus) with perphenazine enanthate and zuclopenthixol acetate.
    Huber C; Walzer C; Slotta-Bachmayr L
    J Zoo Wildl Med; 2001 Sep; 32(3):329-35. PubMed ID: 12785681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
    Burger ME; Fachinetto R; Zeni G; Rocha JB
    Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men.
    Lindholm H; Gullberg B; Ohman A; Sedvall G
    Psychopharmacology (Berl); 1978 Apr; 57(1):1-4. PubMed ID: 96459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiphasic prolactin release and mammary development in virgin rats after prolonged treatment with perphenazine or perphenazine sulphoxide.
    Shani J; Givant Y; Goldhaber G; Sulman FG
    J Endocrinol; 1976 Aug; 70(2):311-2. PubMed ID: 965888
    [No Abstract]   [Full Text] [Related]  

  • 15. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of perphenazine enanthate on open-field test behaviour and stress-induced hyperthermia in domestic sheep.
    Pedernera-Romano C; Ruiz de la Torre JL; Badiella L; Manteca X
    Pharmacol Biochem Behav; 2010 Jan; 94(3):329-32. PubMed ID: 19799930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effects of quaternary neuroleptics on human prolactin and adenylcyclase.
    Langer G; Ahn HS; Perel JM; Makman MH; Sachar EJ
    Lancet; 1977 Feb; 1(8009):493. PubMed ID: 65604
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia.
    Beyeler A; Kadiri N; Navailles S; Boujema MB; Gonon F; Moine CL; Gross C; De Deurwaerdère P
    Neuroscience; 2010 Aug; 169(1):158-70. PubMed ID: 20447448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.